Bracken Lane Partners

Bracken Lane PartnersBracken Lane PartnersBracken Lane Partners

Bracken Lane Partners

Bracken Lane PartnersBracken Lane PartnersBracken Lane Partners
  • Home
  • About us
  • Services Provided
  • Owner Resources
  • Client Success
    • Select Case Studies
    • Past Clients
  • More
    • Home
    • About us
    • Services Provided
    • Owner Resources
    • Client Success
      • Select Case Studies
      • Past Clients
  • Home
  • About us
  • Services Provided
  • Owner Resources
  • Client Success
    • Select Case Studies
    • Past Clients

The Principals at Bracken Lane Partners have over 30 years of combined experience working with private companies in many different industries and have completed over 50 transactions.

Select M&A Transactions

Lux Dynamics

  • LUX Dynamics manufactures specification-grade, LED high bay lighting fixtures with a focus on designing and engineering premium fixtures. 


  • LUX Dynamics differentiates its fixtures through an emphasis of durability, high lumen output, color rendering, and high-quality uniform lighting 


  •  LUX Dynamics is recapitalized by Rock Island Capital and management 

International Test Solutions, Inc.

  • International Test Solutions is a high growth, high margin business and a leading global supplier of highly engineered materials used to optimize semiconductor testing equipment.  


  • Company had received 2 unsolicited offers in the $60M range. Owners felt offers were low, and engaged the principals at Bracken Lane Partners to design a process and market the company.


  • Spent significant time with management preparing the story to best position the platform.


  • Worked with management to articulate their growth trajectory and build a defensible strategy for newer products and initiatives


  • Launched a “full-process” targeting industry strategics and PE firms who are focused on specialty materials and chemicals


  • Ultimately sold to CMC Materials, a publicly traded strategic firm, for $125 million in cash.

Paragon BioTeck, Inc.

  • Paragon Bioteck, Inc. is an eye-care focused drug development company, having a primary emphasis on the early detection of ocular diseases. 


  • Owner was interested in selling the company and engaged the principals of Bracken Lane Partners to design and execute a sale process.


  • Spent significant time with company to prepare “story” and financial model that reflected the current approved drug products as well as the robust pipeline drugs.


  • Prior to launching a full process, “checked in” with a large strategic company in the industry. They had an interest in the approved drugs, but not the pipeline.


  • Ultimately split the company up and sold the approved drugs for cash, and retained the pipeline drugs for future development.

SELECT STRATEGIC ADVISORY CLIENTS

Advisor to the Co-Founder of Clutch over a multi-year period. Provided guidance on real estate partnership, geographic expansion, comparable transactions, and ownership transition.

Fourth generation construction services company. Assisted CEO with Company growth plan, market insight, and value enhancement initiatives.

 Includes transactions completed by Bracken Lane Partners principals while at a former firm. 

Services involving securities are offered by Burch and Company, Inc, member FINRA / SIPC.  Bracken Lane Partners LLC and Burch and Company, Inc are not affiliated entities.

Copyright © 2023 Bracken Lane Partners - All Rights Reserved.

  • Contact Us

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept